Eli Lilly And Stock Filter Stocks by Fundamentals
| LLY Stock | EUR 763.20 23.30 2.96% |
Eli Lilly and fundamentals help investors to digest information that contributes to Eli Lilly's financial success or failures. It also enables traders to predict the movement of Eli Stock. The fundamental analysis module provides a way to measure Eli Lilly's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eli Lilly stock.
Eli |
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Eli Fundamentals
| Return On Equity | 0.63 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 337.36 B | |||
| Shares Outstanding | 952.35 M | |||
| Shares Owned By Insiders | 0.10 % | |||
| Shares Owned By Institutions | 84.35 % | |||
| Price To Earning | 12.38 X | |||
| Price To Book | 34.47 X | |||
| Price To Sales | 11.21 X | |||
| Revenue | 28.54 B | |||
| Gross Profit | 21.91 B | |||
| EBITDA | 8.66 B | |||
| Net Income | 6.24 B | |||
| Cash And Equivalents | 2.2 B | |||
| Cash Per Share | 2.39 X | |||
| Total Debt | 14.74 B | |||
| Debt To Equity | 648.20 % | |||
| Current Ratio | 1.12 X | |||
| Book Value Per Share | 11.83 X | |||
| Cash Flow From Operations | 7.08 B | |||
| Earnings Per Share | 6.49 X | |||
| Price To Earnings To Growth | 2.21 X | |||
| Target Price | 407.12 | |||
| Number Of Employees | 39 K | |||
| Beta | 0.35 | |||
| Market Capitalization | 275.94 B | |||
| Total Asset | 49.49 B | |||
| Z Score | 10.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 2.42 % | |||
| Net Asset | 49.49 B | |||
| Last Dividend Paid | 3.92 |
About Eli Lilly Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eli Lilly and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eli Lilly using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eli Lilly and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Eli Stock
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.